WANG Liqun（Richard）
CEO Fosun Kite Biotechnology Co. Ltd.
Having spent close to 20 years in R&D and management positions in both multinational and Chinese biopharmaceutical companies, he has taken senior roles with increasing leadership responsibilities in Procter & Gamble Pharmaceutical, Bristol-Myers Squibb in the US, AstraZeneca Innovation Center and GSK R&D Center in China.
Prior to Fosun Kite, Richard was the Chief Operation Officer of Cellular Biomedicine Group, where he was in charge of the company’s cell therapy pipeline including manufacturing, clinical development and registration. He was also the GM for the stem cell therapy business unit of the company.
